AHA: AI Analysis of Images, Videos Can ID Early Hypertension, Diabetes
By Lori Solomon HealthDay Reporter
MONDAY, Nov. 18, 2024 -- Machine learning analysis of photo and video data demonstrates a promising way to noninvasively detect early hypertension and diabetes, according to a study presented at the American Heart Association Scientific Sessions 2024, held from Nov. 16 to 18 in Chicago.
Ryoko Uchida, from University of Tokyo, and colleagues developed a machine learning algorithm to analyze skin blood flow and spectral features from photos to noninvasively assess biometric information for health monitoring. The analysis included images from approximately 200 participants' faces and hands, as well as blood pressure readings.
The researchers reported that the algorithm detected hypertension with 94.2 percent alignment with the American Heart Association guidelines for stage 1 hypertension, based on pulse wave features. Among 40 percent who had early hypertension, accuracy rates were 86.2 percent for 30-second data segments and 80.9 percent for 5-second segments. When applying the algorithm to video data, it achieved a 75.3 percent accuracy in detecting diabetes, utilizing blood flow patterns as markers.
"This method may someday allow people to monitor their own health at home and could lead to early detection and treatment of high blood pressure and diabetes in people who avoid medical exams and blood tests," Uchida said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
ADA: Ecnoglutide Yields Superior, Sustained Reduction in Body Weight
MONDAY, June 23, 2025 -- For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon like peptide 1 receptor agonist...
Semaglutide Offers Cardiovascular Edge Over Empagliflozin in Type 2 Diabetes
FRIDAY, June 20, 2025 -- For patients aged 45 years or older with type 2 diabetes, semaglutide seems to confer some advantage over empagliflozin in terms of mortality and...
Hypertension Is Most Common Chronic Condition in People Aged 85 Years and Older
FRIDAY, June 20, 2025 -- Hypertension is the most common chronic condition among adults aged 85 years and older, with prevalence higher among women than men, according to a report...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.